Attached files

file filename
EX-21.1 - EX-21.1 - Sensei Biotherapeutics, Inc.d43789dex211.htm
EX-10.11 - EX-10.11 - Sensei Biotherapeutics, Inc.d43789dex1011.htm
EX-10.9 - EX-10.9 - Sensei Biotherapeutics, Inc.d43789dex109.htm
EX-10.8 - EX-10.8 - Sensei Biotherapeutics, Inc.d43789dex108.htm
EX-10.7 - EX-10.7 - Sensei Biotherapeutics, Inc.d43789dex107.htm
EX-10.6 - EX-10.6 - Sensei Biotherapeutics, Inc.d43789dex106.htm
EX-10.5 - EX-10.5 - Sensei Biotherapeutics, Inc.d43789dex105.htm
EX-10.4 - EX-10.4 - Sensei Biotherapeutics, Inc.d43789dex104.htm
EX-10.3 - EX-10.3 - Sensei Biotherapeutics, Inc.d43789dex103.htm
EX-10.1 - EX-10.1 - Sensei Biotherapeutics, Inc.d43789dex101.htm
EX-4.2 - EX-4.2 - Sensei Biotherapeutics, Inc.d43789dex42.htm
EX-3.2 - EX-3.2 - Sensei Biotherapeutics, Inc.d43789dex32.htm
EX-3.1 - EX-3.1 - Sensei Biotherapeutics, Inc.d43789dex31.htm
EX-2.1 - EX-2.1 - Sensei Biotherapeutics, Inc.d43789dex21.htm
S-1 - S-1 - Sensei Biotherapeutics, Inc.d43789ds1.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated November 12, 2020 relating to the financial statements of Sensei Biotherapeutics, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

Baltimore, Maryland

January 15, 2021